Danieletto Carolina Ferrairo, Ferreira Gustavo Zanna, Farah Gustavo Jacobucci, Cuman Roberto Kenji Nakamura
Master Student, Implantodonty, Araçatuba Dentistry School, UNESP - Universidade Estadual Paulista, Araçatuba, São Paulo, Brazil.
Professor, Dental Surgery, Department of Dentistry, UNICESUMAR - Cesumar University Center, Maringá, Paraná, Brazil.
Spec Care Dentist. 2017 Jan;37(1):38-42. doi: 10.1111/scd.12182. Epub 2016 Apr 5.
Thrombocytopenia is the reduction in the number of blood -platelets, which may be caused by -several different conditions such as sepsis, disseminated intravascular -clotting, and large blood losses. Additionally, in rare situations, thrombocytopenia may also be induced by the use of medicaments. One of these drugs is the vancomycin, a glycopeptide presently used against -serious infections involving Gram-positive bacteria such as the methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus.
The objective of this study is to report on a case of serious vancomycin-induced thrombocytopenia in a patient infected with methicillin-resistant S. aureus after mandibular reconstruction with autogenous bone graft, and to draw attention to the importance of this clinically rare adverse effect.
Vancomycin-induced thrombocytopenia is a rare condition, which is also a significant disorder that demands attention and the rapid identification and replacement of the antimicrobial agent.
血小板减少症是指血液中血小板数量减少,这可能由多种不同情况引起,如败血症、弥散性血管内凝血和大量失血。此外,在罕见情况下,使用药物也可能诱发血小板减少症。其中一种药物是万古霉素,这是一种糖肽类药物,目前用于治疗涉及革兰氏阳性菌的严重感染,如耐甲氧西林金黄色葡萄球菌和耐青霉素链球菌感染。
本研究旨在报告1例耐甲氧西林金黄色葡萄球菌感染患者在自体骨移植下颌骨重建术后发生严重万古霉素诱导的血小板减少症的病例,并提醒人们关注这种临床罕见不良反应的重要性。
万古霉素诱导的血小板减少症是一种罕见病症,也是一种需要关注并迅速识别及更换抗菌药物的重要疾病。